Related Experiment Video
Updated: Mar 6, 2026

An Integrated Platform for Genome-wide Mapping of Chromatin States Using High-throughput ChIP-sequencing in Tumor Tissues
Published on: April 5, 2018
The cancer epigenome: Concepts, challenges, and therapeutic opportunities
1Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia; Centre for Cancer Research, University of Melbourne, Melbourne, VIC, Australia; and Department of Haematology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
Abstract:
Cancer biology is profoundly influenced by changes in the epigenome. Because the dynamic plasticity of the epigenome lends itself well to therapeutic manipulation, the past few years have witnessed an unprecedented investment in the development, characterization, and translation of targeted epigenetic therapies. In this review, I provide a broad context for recent developments that offer a greater understanding of how epigenetic regulators facilitate the initiation, maintenance, and evolution of cancer. I discuss newly developed epigenetic therapies and the cellular and molecular mechanisms that may govern sensitivity and resistance to these agents. I also review the rationale for future combination therapies involving existing and emerging epigenetic drugs.
Insights
Epigenetic alterations drive cancer development and evolution. This review covers new epigenetic therapies targeting cancer, exploring mechanisms of sensitivity, resistance, and future combination strategies.
Area of Science:
- Oncology
- Epigenetics
- Cancer Biology
Background:
- Epigenetic modifications play a crucial role in cancer biology.
- The epigenome's plasticity allows for therapeutic intervention.
- Recent advancements focus on targeted epigenetic therapies for cancer.
Purpose of the Study:
- To provide a comprehensive overview of recent developments in epigenetic therapies for cancer.
- To elucidate the role of epigenetic regulators in cancer initiation, maintenance, and evolution.
- To discuss mechanisms of sensitivity and resistance to epigenetic agents and explore future combination therapies.
Main Methods:
- Review of current literature on epigenetic regulators in cancer.
- Analysis of newly developed epigenetic therapies.
- Examination of cellular and molecular mechanisms governing treatment response.
- Exploration of rationale for combination epigenetic drug therapies.
Main Results:
- Epigenetic regulators are key drivers in cancer initiation, maintenance, and evolution.
- Novel epigenetic therapies are emerging with potential for cancer treatment.
- Understanding mechanisms of sensitivity and resistance is crucial for therapeutic success.
- Combination therapies involving epigenetic drugs show promise for enhanced efficacy.
Conclusions:
- Targeted epigenetic therapies represent a significant advancement in cancer treatment.
- Further research into resistance mechanisms and combination strategies is warranted.
- Epigenetic drugs hold potential for improving patient outcomes in oncology.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

